CTRI/2018/07/015063尚未招募不适用
Comparative study of efficacy of itraconazole and terbinafine with different doses and combination in the treatment of Tinea
IMS BHU1 个研究点 分布在 1 个国家目标入组 275 人开始时间: 2018年6月8日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 275
- 试验地点
- 1
- 主要终点
- Complete clearance of skin lesions
研究概览
简要总结
this is a comparative study with two drugs (terbinafine and itraconazole) with recommended daily doses, double daily doses and combination of both drugs with daily doses. Total study period is of 8 weeks.
primary and secondary outcomes are complete clearing of skin lesions.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 12.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Tinea cruris Tinea corporis Tinea faciei.
排除标准
- •weight more than 80 kg Any other co-morbidities like hepatic disorders, renal disorders, cardiac disorders, etc.
- •history of oral antifungal agents within one month of start of study.
结局指标
主要结局
Complete clearance of skin lesions
时间窗: every 2 weeks for 8 weeks
次要结局
- Experienced as primary outcome.(Every 2 weeks for 8 weeks.)
研究者
研究点 (1)
Loading locations...
相似试验
终止
2 期
Evaluation of the Response of Itraconazole and Terbinafine Therapy in Subjects With Crohn's DiseaseInflammatory Bowel DiseasesCrohn's DiseaseNCT05049525Montreal Heart Institute16
尚未招募
Unknown
Comparison of Terbinafine and Itraconazole in patients of tinea crurisCTRI/2023/05/052604AGMC GBP Hospital
尚未招募
不适用
Study of absorption and elimination rate of Itraconazole 100-mg capsule in comparison with Itraconazole brand Capsule (Sporanox®).IRCT20200407046981N25Kimiara Heram Company24
已完成
不适用
Comparison of Terbinafine and Itraconazole in patients of tinea crurisCTRI/2023/05/052604AGMC GBP Hospital170
尚未招募
3 期
Efficacy and safety of itraconazole, SUBA-itraconazole and voriconazole in Recalcitrant Dermatophytosis.CTRI/2024/05/066681I